Slebos, D., Herth, F., Eberhardt, R., Gompelmann, D., & Rump, B. (2019). Safety and adverse events after targeted lung denervation for symptomatic moderate to severe chronic obstructive pulmonary disease (AIRFLOW): A multicenter randomized controlled clinical trial. American journal of respiratory and critical care medicine, 200(12), . https://doi.org/10.1164/rccm.201903-0624OC
Chicago-Zitierstil (17. Ausg.)Slebos, Dirk-Jan, Felix Herth, Ralf Eberhardt, Daniela Gompelmann, und Brigitte Rump. "Safety and Adverse Events After Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW): A Multicenter Randomized Controlled Clinical Trial." American Journal of Respiratory and Critical Care Medicine 200, no. 12 (2019). https://doi.org/10.1164/rccm.201903-0624OC.
MLA-Zitierstil (9. Ausg.)Slebos, Dirk-Jan, et al. "Safety and Adverse Events After Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW): A Multicenter Randomized Controlled Clinical Trial." American Journal of Respiratory and Critical Care Medicine, vol. 200, no. 12, 2019, https://doi.org/10.1164/rccm.201903-0624OC.